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Identification and Functional Evaluation of Anti-Cancer IImmunomodulators
from Physalis peruviana (Poha)
Department of Biological Sciences
Haley Huggins, Stephanie Brierley, Alyssa Shearer, Alicia Burns, Iris Yang, Ashlee Tietje, Yanzhang Wei
Abstract
Our Creative Inquiry team is researching the anti-tumor
potential of compounds isolated from Physalis peruviana
(poha) fruit. CellTiter 96 Aqueous Non-radiative Cell
Proliferation Assays (Promega, 2012) were performed to
screen the inhibitory activity of the compounds on human
lung carcinoma A549 cells and breast cancer MDA-MB231 cells with the corresponding non-tumorigenic
epithelial cell line NL20 and MCF-10A as controls. The
cells were treated with compounds at concentrations of
0μg/ml, 2μg/ml, 5μg/ml, and 20μg/ml and incubated for
24, 48, and 72 hours.

Results and Discussions
Results

Figure 1. Breast cancer cell proliferation after 24 hours of incubation.

Figure 2. Breast cancer cell proliferation after 48 hours of incubation.

Figure 3. Breast cancer cell proliferation after 72 hours of incubation.

Introduction
Native to South America, the Physalis peruviana (poha) plant has
been widely introduced around the world particularly in Hawaii as a
cultivated fruit, a medicinal plant and as an ornamental (CABI,
2015). Poha has been claimed to be beneficial for a number of
human diseases. However, there is very limited scientific evidence
to support these claims. We believe that the confirmation of antitumor potential of these poha derived compounds will provide
cancer patients with more treatment options.
The samples used by this project are extracts from the plant’s
fruits produced by the collaboration laboratory at the University of
Hawaii. The MTS assay performed determines the number of viable
cells in proliferation. MTS is a substrate that can be reduced by
cells into a formazan product that is soluble in tissue culture media
(Promega, 2012). The amount of absorbance of the formazan
product at 490nm is directly proportional to the number of living
cells in culture (Cory, 1991).

Figure 4. Breast cancer cell proliferation when
treated with sample PPE37A at concentrations
2ug/ml, 5ug/ml, and 20ug/ml.

Figure 5. Breast cancer cell proliferation when
treated with sample PPE28 at concentrations
2ug/ml, 5ug/ml, and 20ug/ml.

Figure 6. Breast cancer cell proliferation when
treated with sample PPE28A at concentrations
2ug/ml, 5ug/ml, and 20ug/ml.

Figure 7. Breast cancer cell proliferation when
treated with sample PPE21_2P3P at concentrations
2ug/ml, 5ug/ml, and 20ug/ml.

The results showed a greatest reduction in cell
proliferation when treated with samples PPE37A, PPE28,
PPE28A and PPE21_2P3P in the MDA-MB-231 cells as
seen by a fold change less than 1. In the A549 cells,
PPE28A and PPE21_2P3P presented promising results.
The cells showed a sample dose dependence with the
greatest decrease in proliferation for the higher treatment
concentration (20ug/ml). The cell proliferation also showed
a dependence on incubation time displaying a greatest
reduction in proliferation on average when incubated for 72
hours.
Sample PPE21_2P3P at 72 hours was found to be the
most promising sample for both cell lines and the assay was
repeated to compare the cancer cell lines with normal cell
lines. Ideally, the samples would decrease the cancer cell
proliferation but remained ineffective on the normal cell
lines. This trend was observed showing a fold change of 1
in the MCF-10A and NL20 cells and a fold change below 1
in the MDA-MB-231 and A549 cells treated with samples at
concentration of 5ug/ml.

Conclusion

Figure 8: Lung cancer cell proliferation after 24 hours.

Figure 9: Lung cancer cell proliferation after 48 hours.

Figure 10: Lung cancer cell proliferation after 72 hours.

The sample PPE21_2P3P with a concentration of 5 ug/mL was
found to be the most promising sample for both the MDA-MB-231 and
A549 cell lines. A fold change under 1 was observed for both of the cell
lines, indicating a decrease in cell proliferation due to the sample. The
sample PPE21_2P3P was also found to not inhibit cell proliferation of the
normal cell lines MCF-10A and NL20. This is because a fold change
above 1 was observed for both cell lines, indicating that cell proliferation
was unaffected by the addition of the sample. Future directions include
another round of sample PPE21_2P3P at 72 hours to confirm results and
testing of the sample PPE21_2P3P on new cell lines.
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Methods
The cells are first thawed and cultured by changing the media
every two days. Once enough cells are cultured, they are plated
in 96-well plates with 5,000 cells per well in 200ul of media. The
plated cells are treated with 5ul of poha samples at 2ug/mL,
5ug/mL and 20 ug/mL concentrations in triplicates. The controls
include triplicates of media not treated with poha samples to
detect contamination in the cells as well as triplicates of DMSO
at 2ug/mL, 5ug/mL and 20 ug/mL concentrations which is used
as a solvent for the samples. The DMSO control will serves as a
baseline to determine if the poha sample had an effect on cell
proliferation.
The MTS cell proliferation assay is performed after 24, 48,
and 72 hours of incubation and the absorbance of each plate is
recorded. The average absorbance of the sample triplicates are
taken and compared with the DMSO controls. The fold
difference of each sample at the three time points are graphed.

Figure 11: Lung cancer cell proliferation when treated with
sample PPE28A at concentrations 2ug/mL. 5 ug/mL and 20
ug/mL.

Figure 13. Normal and cancerous breast cell lines after treated with
PPE21_2P3P and incubated for 72 hrs. MCF-10A serving as normal cell line
control.

Figure 12: Lung cancer cell proliferation when treated with
sample PPE21_2P3P at concentrations 2ug/mL. 5 ug/mL and
20 ug/mL.

Figure 14. Normal and cancerous lung cell lines after treated with
PPE21_2P3P and incubated for 72 hrs. MCF-10A serving as normal cell line
control.
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